FEATURED NEWS

MATEC
October 31, 2019
Updates to section of Vaccine-Preventable Diseases in Children and Adolescents with HIV Infection October 25, 2019: Vaccine-Preventable Diseases in Children and Adolescents with HIV Infection: The Panel updated this section and the recommended immunization schedule to include new vaccines available for the prevention of meningococcal infection (MenACWY-D MORE
MATEC
October 23, 2019
Updates to Several Tables in the Adult and Adolescent Opportunistic Infections Guidelines October 22, 2019: The Panel updated the following tables in the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. The updates include information on new drugs added to the guidelines as well as information MORE
FDA
December 12, 2018
FDA approves TEMIXYS: New HIV Fixed Dose Drug Combination November 27, 2018: FDA recently approved TEMIXYS (lamivudine and tenofovir disoproxil fumarate) tablets, indicated for use in combination with other antiretroviral agents for the treatment of HIV-1 infection in adult and pediatric patients weighing at least 35 kg. TEMIXYS was approved based on two MORE
MATEC
December 12, 2018
GENVOYA renal labeling updates Click here to view full announcement with additional information (webpage) VIREAD HBV label updates (pediatrics) Click here to view full announcement with additional information (website)
MATEC
December 10, 2018
www.matec.info HIV News Alert Updated HHS Perinatal Antiretroviral Treatment Guidelines Released December 7, 2018: The HHS Panel on Treatment of Pregnant Women with HIV Infection and Prevention of Perinatal Transmission (the Panel) is pleased to announce the release of the updated Recommendations for the Use of Antiretroviral Drugs in Pregnant MORE
MATEC
November 27, 2018
OHIO: Increased HIV Transmission through Injection Drug Use The Ohio Department of Health (ODH) is observing an increase in newly diagnosed HIV infections being reported among persons who inject drugs (PWID). While HIV remains predominantly a sexually transmitted infection, the proportion of cases reporting injection drug use (IDU) as the mode of MORE
MATEC
March 9, 2018
Updates to the Human Papillomavirus Disease Section of the Adult and Adolescent Oppotunistic Infections Guidelines Last updated: March 7, 2018; Last Reviewed: March 7, 2018 The Human Papillomavirus Disease section of the Guidlines for the Prevention and Treatment of Opportunistic Infections in HIV-infected Adults and adolescents was updated on March MORE
MATEC
October 20, 2017
Perinatal Antiretroviral Treatment Guidelines Updated October 19, 2017: The Recommendations for the use of Antiretroviral Drugs in Pregnant Women with HIV Infection and Interventions to Reduce Perinatal HIV Transmission in the United States were recently updated. The following is a summary of what's changed in this revision: Recommendations for Use of MORE
MATEC
October 20, 2017
HHS Adult and Adolescent Antiretroviral Treatment Guidelines Updated The HHS Panel on Antiretroviral Guidelines for Adults and Adolescents (the Panel) has released an updated version of the Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV Key guideline updates include the following: In the What to Start MORE
FDA
October 13, 2017
FDA Approved changes to the Sustiva label, Genvoya, Norvir, Descovy and more. On October 12, 2017 the FDA approved changed to the Sustiva (efavienz) package insert to: Update information on hepatotoxicity in DOSAGE and ADMINISTRATION, WARNINGS AND PRECAUTIONS, ADVERSEREACTIONS and Patient Information sections. Update CONTRAINDICATIONS and MORE
MATEC
August 17, 2017
Adult and Adolescent Opportunistic Infections Guidlines Updated The following sections of the Guidelines for the Prevemtion and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents have recently been updated: Hepatitis B Virus infection: This section was updated to include TAF/FTC as a treatment option for patients with HBV/HIV MORE
MATEC
August 1, 2017
Adult and Adolescent Opportunistic Infections Guidelines Updated July 28, 2017: The following sections of the Guidlines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents have recently been updated: Click here to view recently updated guidlines Sections of the Pneumocystis guidlines have been MORE

Pages